BIOATLA INC
BCAB
BCAB was delisted on the 28th of August, 2026.
39 hedge funds and large institutions have $5.21M invested in BIOATLA INC in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 8 closing their positions.
9% more capital invested
Capital invested by funds: $4.77M → $5.21M (+$447K)
0.02% less ownership
Funds ownership: 0.47% → 0.45% (-0.02%)
7% less funds holding
Funds holding: 42 → 39 (-3)
27% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 11
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Acorn Capital Advisors
New York
|
+$326K |
| 2 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$69.1K |
| 3 |
ACI
Alpha Cubed Investments
Irvine,
California
|
+$16.7K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$16.7K |
| 5 |
MCM
MAI Capital Management
Independence,
Ohio
|
+$14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$114K |
| 2 |
Squarepoint
New York
|
-$90.3K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$81K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$80.1K |
| 5 |
Two Sigma Advisers
New York
|
-$70.9K |
BCAB Hedge Fund Activity: Q2 2025 in Review
39 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in BIOATLA INC (BCAB) for Q2 2025, worth a combined $5.21M — up 9.4% from $4.77M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of BCAB and 5 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 8 added.
The largest buyer was Acorn Capital Advisors, adding an estimated $326K. The largest seller was Morgan Stanley, cutting an estimated $114K.
- 39 institutional investors held BIOATLA INC (BCAB) as of Q2 2025, down from 42 in Q1 2025.
- Funds reported $5.21M of BIOATLA INC stock for Q2 2025, up 9.4% quarter-over-quarter.
- 5 funds opened new BIOATLA INC positions in Q2 2025 and 8 closed out, a net change of -3 holders.
- The largest BIOATLA INC buyer in Q2 2025 was Acorn Capital Advisors, an estimated $326K added.
- The largest BIOATLA INC seller in Q2 2025 was Morgan Stanley, an estimated $114K sold.
Based on aggregated 13F filings for Q2 2025.